Publication

Editorial: Innovative biologics and drugs to target renal inflammation

Griffin, Matthew D.
; 
Swaminathan, Sundararaman
Thumbnail Image
Files
Thumbnail Image
Griffin_and_Swaminathan_Editorial_for_Research_Topic_REVISED.pdf
Adobe PDF, 204.11 KB
Repository DOI
Publication Date
2020-02-06
Keywords
Chronic Kidney Disease, Acute Kidney Injury, Inflammation, Therapeutic Targets, Diabetic Nephropathy, Sepsis, Interstitial Fibrosis, Biologic Agents, CHRONIC KIDNEY-DISEASE, INHIBITION, BURDEN
Type
Article
Downloads
Show all metadata
Citation
Griffin, Matthew D., & Swaminathan, Sundararaman. (2020). Editorial: Innovative Biologics and Drugs to Target Renal Inflammation. Frontiers in Pharmacology, 11(38). doi:10.3389/fphar.2020.00038
Abstract
[No abstract available]
Funder
National Institutes of Health
Horizon 2020
Seventh Framework Programme
Science Foundation Ireland
European Regional Development Fund
Publisher
Frontiers Media
Publisher DOI
10.3389/fphar.2020.00038
Rights
Attribution-NonCommercial-NoDerivs 3.0 Ireland
cbn
Collections
Regenerative Medicine Institute (Scholarly Articles)